1. Home
  2. PFIS vs EYPT Comparison

PFIS vs EYPT Comparison

Compare PFIS & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PFIS
  • EYPT
  • Stock Information
  • Founded
  • PFIS 1905
  • EYPT 1987
  • Country
  • PFIS United States
  • EYPT United States
  • Employees
  • PFIS N/A
  • EYPT N/A
  • Industry
  • PFIS Major Banks
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • Sector
  • PFIS Finance
  • EYPT Industrials
  • Exchange
  • PFIS Nasdaq
  • EYPT Nasdaq
  • Market Cap
  • PFIS 548.2M
  • EYPT 594.5M
  • IPO Year
  • PFIS N/A
  • EYPT 2005
  • Fundamental
  • Price
  • PFIS $53.89
  • EYPT $7.44
  • Analyst Decision
  • PFIS Hold
  • EYPT Strong Buy
  • Analyst Count
  • PFIS 1
  • EYPT 8
  • Target Price
  • PFIS $47.00
  • EYPT $27.29
  • AVG Volume (30 Days)
  • PFIS 31.5K
  • EYPT 898.1K
  • Earning Date
  • PFIS 01-23-2025
  • EYPT 11-07-2024
  • Dividend Yield
  • PFIS 4.48%
  • EYPT N/A
  • EPS Growth
  • PFIS N/A
  • EYPT N/A
  • EPS
  • PFIS 0.78
  • EYPT N/A
  • Revenue
  • PFIS $96,196,000.00
  • EYPT $45,713,000.00
  • Revenue This Year
  • PFIS N/A
  • EYPT N/A
  • Revenue Next Year
  • PFIS $34.97
  • EYPT N/A
  • P/E Ratio
  • PFIS $71.23
  • EYPT N/A
  • Revenue Growth
  • PFIS N/A
  • EYPT 7.50
  • 52 Week Low
  • PFIS $36.26
  • EYPT $7.21
  • 52 Week High
  • PFIS $59.70
  • EYPT $30.99
  • Technical
  • Relative Strength Index (RSI)
  • PFIS 55.62
  • EYPT 36.37
  • Support Level
  • PFIS $54.35
  • EYPT $7.21
  • Resistance Level
  • PFIS $56.60
  • EYPT $8.21
  • Average True Range (ATR)
  • PFIS 1.47
  • EYPT 0.54
  • MACD
  • PFIS -0.24
  • EYPT -0.06
  • Stochastic Oscillator
  • PFIS 45.05
  • EYPT 11.39

About PFIS Peoples Financial Services Corp.

Peoples Financial Services Corp is a bank holding company operating through its subsidiaries. The bank provides a full range of financial services. Its products and services include checking accounts, business accounts, savings accounts, loan products, money market accounts, mortgages, chip-enabled debit cards, credit card processing, and visa master card and advisory services. Its loan portfolio includes Commercial loans, which consist of commercial, commercial real estate, municipal, and other related tax-free loans; and retail loans, which include residential real estate and other consumer loans. The company mainly operates in the United States in Pennsylvania.

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

Share on Social Networks: